Moderating effect of obesity on clinical outcomes in NOAC-treated atrial fibrillation patients or just an effect of obesity?
- PMID: 32505330
- DOI: 10.1016/j.ijcard.2020.03.070
Moderating effect of obesity on clinical outcomes in NOAC-treated atrial fibrillation patients or just an effect of obesity?
Conflict of interest statement
Declaration of competing interest None to declare.
Comment in
-
On interactions between body mass index, type of anticoagulation and outcomes.Int J Cardiol. 2020 Aug 1;312:107. doi: 10.1016/j.ijcard.2020.04.064. Int J Cardiol. 2020. PMID: 32505328 No abstract available.
Comment on
-
Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.Int J Cardiol. 2020 Feb 15;301:90-95. doi: 10.1016/j.ijcard.2019.10.035. Epub 2019 Oct 30. Int J Cardiol. 2020. PMID: 31748190
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
